---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "DeNJziPLA10Lht+JALs3xVyL248aOGSNQxP+a+Y65sXyVlKcFrSCSNxyYER8I/7izdDyKTZROP5ZmleH8CdYZ63WHZubYfEh05A8QmcJMzE1ESh3wF5kiQi16uzF2HD9ivItuqABbkAdSfAS3/3rjTE/6EDla/StZiLjb/AmFV6elwk389uQ3xNAo2qLh8SS94LGwXvE7RKyi0Yb3vLq6Ma4CwP44BFP4TNeJXX8Xqh0fKMWs/NryAM97PsFL3n5QOtAskUouVLhtJ4v4kOky1FHpbYQks9yQIgnc8d4V5q81jM0Hc/TW30LVumpVXGSPA1y74vtwobWyjzzPf4R4d61mhnb9+UGwxIJwgbr5PY=;Z5dk/4Rl1Po3HFIbpZA9Rw=="
---

